Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
5.10
+0.06 (1.19%)
At close: Apr 27, 2026, 4:00 PM EDT
5.32
+0.22 (4.31%)
Pre-market: Apr 28, 2026, 4:39 AM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $10.13 million as of April 27, 2026. Its market cap has increased by 250.17% in one year.
Market Cap
10.13M
Enterprise Value
5.45M
1-Year Change
250.17%
Ranking
Category
Stock Price
$5.10
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $10.13M, a decrease of -99.99%. That is a compound annual growth rate of -83.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 10.13M | 172.59% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 11.25M |
| Lunai Bioworks | 11.25M |
| Imunon | 10.94M |
| Aprea Therapeutics | 10.65M |
| Kiora Pharmaceuticals | 10.31M |
| Quoin Pharmaceuticals | 10.28M |
| Evogene | 9.92M |
| GT Biopharma | 9.86M |